Trading a ELVN straddle lets you take a pure volatility position on Enliven Therapeutics Inc without committing to a direction. Enliven Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ELVN straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on ELVN profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Enliven Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ELVN straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the ELVN straddle is the cleanest expression of that view. Our scanner prices every ELVN straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ELVN straddle into a catalyst or short a ELVN straddle to harvest decay, the options straddle setups that matter are all in one place.
